Page last updated: 2024-10-26

diphenhydramine and B-Cell Chronic Lymphocytic Leukemia

diphenhydramine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolbusz, RV1
Micetich, K1
Armin, AR1
Massa, MC1

Other Studies

1 other study available for diphenhydramine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Exaggerated response to insect bites. An unusual cutaneous manifestation of chronic lymphocytic leukemia.
    International journal of dermatology, 1989, Volume: 28, Issue:3

    Topics: Diphenhydramine; Female; Humans; Hypersensitivity, Delayed; Insect Bites and Stings; Leukemia, Lymph

1989